Antitumor effects of IST-622, a novel synthetic derivative of chartreusin, against murine and human tumor lines following oral administration

Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses

Tazuko Tashiro, Makoto Inaba, Tomowo Kobayashi et al. · Cancer Chemotherapy and Pharmacology · 1989 · 42 citations

Medicine, Oncology, Pharmacology +5

Antitumor activity and preliminary drug disposition studies on chartreusin (NSC 5159).

McGovren Jp, Neil Gl, Crampton Sl et al. · PubMed · 1977 · 36 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Synthesis and cytostatic activity of the antitumor antibiotic chartreusin derivatives.

Kenji Kon, Hideo Sugi, KIYOSHI TAMAI et al. · The Journal of Antibiotics · 1990 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Experimental antitumor activity of BMY-28090, a new antitumor antibiotic

John E. Schurig, William T. Bradner, George A. Basler et al. · Investigational New Drugs · 1989 · 14 citations

Medicine, Medicinal Chemistry, Pharmacology +2

Phase I trial and clinical pharmacology of elsamitrucin.

Martin N. Raber, Robert A. Newman, Beverly Newman et al. · PubMed · 1992 · 13 citations

Pharmacy, Pharmacology, Toxicology +13